Nationwide drug resistance survey of tuberculosis in the Philippines

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 4, 2009, Pages 500-507

  Mori, Toru ^a,b  

^a Philippine Nationwide Tuberculosis Drug Resistance Survey Teem   (Philippines)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Drug resistance; Philippines; Survey; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PHILIPPINES; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; URBAN AREA;

ADULT; ANTITUBERCULAR AGENTS; DATA COLLECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHILIPPINES; PREVALENCE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 64549138471     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. WHO/HTM/ TB/2007.376. Geneva, Switzerland: WHO, 2007.
2. Tupasi T E, Radhakrishna S, Rivera A B, et al. The 1997 Nationwide Tuberculosis Prevalence Survey in the Philippines. Int J Tuberc Lung Dis 1999; 3: 471-477.
3. Ohkado A, Aguiman L, Adlawan S, et al. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines. Int J Tuberc Lung Dis 2006; 10: 283-289.
4. Rivera A B, Tupasi T E, Balagtas E D, et al. Drug-resistant tuberculosis in the Philippines. Int J Tuberc Lung Dis 1999; 3: 639.
5. Mendoza M T, Gonzaga A J, Roa C, et al. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines. Int J Tuberc Lung Dis 1997; 1: 59-63.
6. Manalo F M, Suntos E N, Ventura D. The prevalence of antituberculosis drug resistance in the Quezon Institute. Chest Dis 1981; 12: 119-132.
7. Gotaco L T, Realiza T M. Evaluation of the AFB smear and culture: St Luke's Medical Center experience. Phil J Chest Dis 1983; 1: 9-12.
8. Rivera A B, Tupasi T E, Balagtas E D. Multidrug-resistant tuberculosis in the Philippines: implications for therapy. Phil J Microbiol Infect Dis 2000; 29: 68-72.
9. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. WHO/CDS/CSR/RMD/2003.3. Geneva, Switzerland: WHO, 2003.
10. World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Report no. 4. The WHO/Union Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 2002-2007. WHO/HTMATB/2008.394. Geneva, Switzerland: WHO, 2008.
11. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. WHO/CDS/TB/2003. 313. Geneva, Switzerland: WHO, 2003.
12. Dye C, Espinal M, Watt C J, Mbiaga C, Williams B. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185: 1197-1202.
13. Zignol M, Hosseini M S, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479- 485.
14. Moniruzzaman A, Elwood R K, Schulzer M, FitzGerald J M. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia. Int J Tuberc Lung Dis 2006; 10: 844-850.
15. Talbot E A, Moore M, McCray E, Binkin N J. Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA 2000; 22: 2894-2900.
16. Manalo F, Tan F, Sbarbaro J A, Iseman M D. Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance. Am Rev Respir Dis 1990; 142: 1301-1305.
17. Yamada N, Saorith K, Yamakami K, et al. The national tuberculosis drug resistance survey in Cambodia, 2000-2001. Int J Tuberc Lung Dis 2007; 11: 1321-1327.
18. Tupasi T E, Radhakrishna S, Co V M, et al. Bacillary disease and health seeking behavior among Filipinos with symptoms of tuberculosis: implications for control. Int J Tuberc Lung Dis 2000; 4: 1126-1132.
19. Auer C, Sarol J Jr, Tanner M, Weiss M. Health seeking and perceived causes of tuberculosis among patients in Manila. Trop Med Int Health 2000; 5: 648-656.
20. Auer C, Lagahid J Y, Tanner M, Weiss M G. Diagnosis and management of tuberculosis by private practitioners in Manila, Philippines. Health Policy 2006; 77: 172-181.
21. Lansang M A, Lucas-Aquino R, Tupasi T E, et al. Purchase of antibiotics without prescription in Manila, the Philippines. Inappropriate choices and doses. J Clin Epidemiol 1990; 43: 61- 67.
22. Mantala M J. Public-private mix DOTS in the Philippines. Tuberculosis 2003; 83: 173-176.
23. Yanase Y, Ohida T, Kaneita Y, et al. The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants. Bull World Health Organ 2007; 85: 131-137.
24. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance: anti-tuberculosis drug resistance in the world. 3rd global report. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 1999-2002. WHO/HTM/TB/2004.343. Geneva, Switzerland: WHO, 2004: pp 93-94.
25. Tupasi T E, Quelapio M I D, Orillaza R B, et al. DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed. Tuberculosis 2003; 83: 52-58.
26. World Health Organization Stop TB Department. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2006.361. Geneva, Switzerland: WHO, 2006.